Circulating levels of a lung protein found to be 'strongly predictive' of cardiovascular disease
A blood protein known as surfactant protein-D (SP-D), which is mainly synthesised in the lungs, has been described as "a good predictor" of cardiovascular disease following a large study in North America. Reporting the study ...
Cardiology
Jun 08, 2011 |
5 / 5 (1) |
0
|
Severity of cystic fibrosis may be determined by presence of newly-identified modifier genes
(Medical Xpress) -- In an age where personalized medicine is within reach, a one-size-fits-all approach just won’t cut it. A group of North American researchers have identified two “modifier” genes in the genomes ...
Genetics
May 25, 2011 |
5 / 5 (1) |
0
|
Study identifies genome regions that could influence severity of cystic fibrosis
A team of researchers, including a number from the University of North Carolina at Chapel Hill School of Medicine, have pinpointed regions of the genome that contribute to the debilitating lung disease that is the hallmark ...
Genetics
May 23, 2011 |
not rated yet |
0
|
Protein could offer target to reduce lung damage from smoking-caused emphysema
An international research team has identified a lung protein that appears to play a key role in smoking-related emphysema and have crafted an antibody to block its activity, Indiana University scientists reported.
Medical research
May 16, 2011 |
not rated yet |
0
|
Gene variant linked with development of COPD in men
Researchers have linked a variant in the vitamin D receptor gene (VDR) with the onset of chronic obstructive pulmonary disease (COPD) in Caucasian men. The study population consisted of participants in the Veterans Administration ...
Diseases, Conditions, Syndromes
May 16, 2011 |
not rated yet |
0
|
Shortage of key drug hampering U.S. efforts to control TB, report says
(HealthDay)—A shortage of a critical tuberculosis drug has hampered the efforts of health departments across the United States to contain the spread of the highly infectious lung disease, federal officials ...
Diseases, Conditions, Syndromes
May 23, 2013 |
not rated yet |
0
Genetic variation among patients with pulmonary fibrosis associated with improved survival
Variation in the gene MUC5B among patients with idiopathic pulmonary fibrosis was associated with improved survival, according to a study published online by JAMA. The study is being released early online to coincide with i ...
Diseases, Conditions, Syndromes
May 21, 2013 |
not rated yet |
0
Combined wood and tobacco smoke exposure increases risk and symptoms of COPD
People who are consistently exposed to both wood smoke and tobacco smoke are at a greater risk for developing chronic obstructive pulmonary disease (COPD) and for experiencing more frequent and severe symptoms of the disease, ...
Health
May 20, 2013 |
not rated yet |
0
Tiny, implantable coil promises hope for emphysema patients
A small, easily implantable device called the Lung Volume Reduction Coil (LVRC) may play a key role in the treatment of two types of emphysema, according to a study conducted in Europe. Results of the study indicate the beneficial ...
Diseases, Conditions, Syndromes
May 20, 2013 |
not rated yet |
0
'Black lung is back' researcher says
The dangers of coal mining enter the spotlight periodically when disasters strike, but one West Virginia University researcher argues that coal mine dust exposure, which has caused an increase in the prevalence and severity ...
Health
May 17, 2013 |
5 / 5 (1) |
0
Fitness in middle age may help shield men from cancer later
(HealthDay)—Men who are physically fit in middle age have a lower risk of developing and dying from certain cancers, new research indicates.
Cancer
May 16, 2013 |
5 / 5 (1) |
0
Scientists develop 'magic bullet' nanomedicine for Acute Lung Injury
Researchers at Queen's University Belfast have devised a 'magic bullet' nanomedicine which could become the first effective treatment for Acute Lung Injury or ALI, a condition affecting 20 per cent of all patients in intensive ...
Medical research
May 15, 2013 |
4 / 5 (1) |
0
FDA approves once-a-day inhaler from Glaxo
The Food and Drug Administration says it has approved a new once-a-day inhaler drug from GlaxoSmithKline for patients with chronic lung disease.
Medications
May 10, 2013 |
not rated yet |
0
Allergic disease worsens respiratory symptoms and exacerbations in COPD
Patients with chronic obstructive pulmonary disease (COPD) who also have allergic disease have higher levels of respiratory symptoms and are at higher risk for COPD exacerbations, according to a new study from researchers ...
Diseases, Conditions, Syndromes
May 10, 2013 |
not rated yet |
0
Ambrisentan not effective in idiopathic pulmonary fibrosis
(HealthDay)—The endothelin A receptor-selective antagonist ambrisentan is not effective for reducing the rate of idiopathic pulmonary fibrosis (IPF) progression, according to a study published in the May ...
Diseases, Conditions, Syndromes
May 07, 2013 |
not rated yet |
0
